(Q37699001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

review article

1 reference

title

Molecular aspects of myeloproliferative neoplasms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Dorota Jeziorowska

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Christophe Marzac

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nicole Casadevall

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

27 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Hematology

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

165-173

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12185-010-0530-z

18 January 2020

exact match

0 references

cites work

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0530-Z

Polycythemia vera is not initiated by JAK2V617F mutation.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-010-0530-Z

X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoies

21 January 2018

1 reference

12 December 2020

Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice

1 reference

12 December 2020

Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor

1 reference

12 December 2020

Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia.

1 reference

12 December 2020

ID1 promotes expansion and survival of primary erythroid cells and is a target of JAK2V617F-STAT5 signaling

1 reference

12 December 2020

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

1 reference

12 December 2020

Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

1 reference

12 December 2020

Acquired mutations in TET2 are common in myelodysplastic syndromes

1 reference

12 December 2020

Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms

1 reference

12 December 2020

Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

1 reference

12 December 2020

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

1 reference

12 December 2020

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms

1 reference

12 December 2020

JAK1 and Tyk2 activation by the homologous polycythemia vera JAK2 V617F mutation: cross-talk with IGF1 receptor.

1 reference

12 December 2020

Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation

1 reference

12 December 2020

Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

1 reference

12 December 2020

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

1 reference

12 December 2020

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

1 reference

12 December 2020

Mutation in TET2 in myeloid cancers

1 reference

12 December 2020

Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

1 reference

12 December 2020

Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia

1 reference

12 December 2020

Aberrant signal transduction pathways in myeloproliferative neoplasms

1 reference

12 December 2020

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

1 reference

12 December 2020

Mutations of ASXL1 gene in myeloproliferative neoplasms.

1 reference

12 December 2020

Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.

1 reference

12 December 2020

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders.

1 reference

12 December 2020

Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

1 reference

12 December 2020

Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

1 reference

12 December 2020

Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model

1 reference

12 December 2020

Somatic and germline genetics at the JAK2 locus.

1 reference

12 December 2020

Myelodysplastic syndromes: lost between two states?

1 reference

12 December 2020

Janus kinases affect thrombopoietin receptor cell surface localization and stability

1 reference

12 December 2020

Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms.

1 reference

12 December 2020

Identification of an acquired JAK2 mutation in polycythemia vera

1 reference

12 December 2020

Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis

1 reference

12 December 2020

Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden

1 reference

12 December 2020

Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera

1 reference

12 December 2020

Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias

1 reference

12 December 2020

The JAK2 617V>F mutation triggers erythropoietin hypersensitivity and terminal erythroid amplification in primary cells from patients with polycythemia vera

1 reference

12 December 2020

The hematopoietic stem cell compartment of JAK2V617F-positive myeloproliferative disorders is a reflection of disease heterogeneity

1 reference

12 December 2020

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice

1 reference

12 December 2020

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

1 reference

12 December 2020

ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1

1 reference

12 December 2020

Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures

1 reference

12 December 2020

A gain-of-function mutation of JAK2 in myeloproliferative disorders

1 reference

12 December 2020

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

1 reference

12 December 2020

An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.

1 reference

12 December 2020

Cbl signaling networks in the regulation of cell function

1 reference

12 December 2020

Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

1 reference

12 December 2020

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

1 reference

12 December 2020

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.

1 reference

12 December 2020

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

1 reference

12 December 2020

Oncogenic mechanisms in myeloproliferative disorders

1 reference

12 December 2020

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

1 reference

12 December 2020

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

12 December 2020

Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?

1 reference

12 December 2020

Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms

1 reference

12 December 2020

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1

1 reference

12 December 2020

Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms

1 reference

12 December 2020

The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor

1 reference

12 December 2020

Cancer: More than kin and less than kind

1 reference

12 December 2020

JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis.

1 reference

12 December 2020

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

1 reference

12 December 2020

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders

1 reference

12 December 2020

10.1007/S12185-010-0530-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20186505%20AND%20SRC:MED&resulttype=core&format=json

release_oqeymxrdrnhvtcjqczldahr52u

18 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqeymxrdrnhvtcjqczldahr52u

24 November 2022

mapped directly with Wikidata item

1 reference